Document is current
Any future updates will be listed below
-
Authors
Fukuda, Taiki https://orcid.org/0000-0001-9173-738X
Yamano, Yasuhiko
Ishida, Kaori
Tanaka, Tomonori
Egashira, Ryoko
Sumikawa, Hiromitsu
Hashisako, Mikiko
Tominaga, Junya
Matsumura, Mai
Ueno, Midori
Yamada, Daisuke
Ko, Yuki
Nakamura, Yusei
Ojiri, Hiroya
Hatabu, Hiroto
Takei, Reoto
Kataoka, Kensuke
Kimura, Tomoki
Kondoh, Yasuhiro
Fukuoka, Junya
Johkoh, Takeshi
,
Komiya, Kosaku
Shimamura, Takashi
Tateishi, Tomoya
Wang, Junping
Yoshidome, Eriko
- License Information
-
More Information
Article History
Received: 15 September 2025
Accepted: 16 November 2025
First Online: 18 December 2025
Declarations
:
: The Collaboration Project of Radiology and Pathology in Diffuse Lung Diseases Research Group received partial support from a grant provided by the Ministry of Health, Labor and Welfare of Japan. This support was not specific to the present work. Y.Y. reports lecture fees from Boehringer Ingelheim, Japan, Inc., and Chugai Pharmaceutical Co., Ltd. R.E. reports lecture fees from Boehringer Ingelheim, Japan, GE HealthCare Pharma. KYORIN Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., and reports receiving support for attending meetings from Boehringer Ingelheim, Japan. H.S. reports lecture fees and reports receiving support for attending meetings from Boehringer Ingelheim, Japan. D.Y. reports research grant fees from Astellas Pharma Inc., Bayer Yakuhin, Ltd. Academic Support, St. Luke’s Health Science Research, and St. Luke’s Breast Cancer Charity Fund. H.H. is supported by grants NIH/NCI R01CA203636, NIH/NCI U01CA209414, NIH/NHLBI R01HL111024, NIH/NHLBI R01HL135142, and NIH/NHLBI R01HL130974, and has the provisional US patent application with the serial number 63/610,842. Brigham and Women’s Hospital is funded with a research grant from Canon Medical Systems Corporation. K.K. reports lecture fees from Nippon Boehringer Ingelheim Co., Ltd. T.K. reports lecture fees from AstraZeneca K.K., Sanofi K.K., Eli Lilly Japan K.K, Boehringer Ingelheim, Chugai Pharmaceutical Co., Ltd., GlaxoSmithKline plc, KYORIN Pharmaceutical Co, Ltd, MSD K.K., Mochida Pharmaceutical Co., LTD., Takeda Pharmaceutical Co, Ltd, Novartis Pharma KK, Insmed Incorporated. Y.Kondoh. reports consulting fees from Asahi Kasei Pharma Corp, Boehringer Ingelheim, Chugai Pharmaceutical Co., Ltd., GlaxoSmithKline plc, Healios K.K., Janssen Pharmaceutical K.K., Mochida Pharmaceutical Co., LTD, Shionogi Co, Ltd., Taiho Pharmaceutical Co., and lecture fees from Asahi Kasei Pharma Corp, Bristol Myers Squibb, Boehringer Ingelheim, Eisai Co, Ltd, Janssen Pharmaceutical K.K., GlaxoSmithKline plc, KYORIN Pharmaceutical Co, Ltd, Mitsubishi Tanabe Pharma, Nippon Shinyaku Co., Ltd, Novartis Pharma K.K., Shionogi Co, Ltd., Teijin Pharma Ltd. J.F. reports lecture fees from Boehringer Ingelheim. T.J. reports lecture fees from AstraZeneca, Boehringer Ingelheim, KYORIN Pharmaceutical Co, Ltd. The remaining authors have no relevant disclosures.
: This study was performed in accordance with the Declaration of Helsinki. This human study was approved by The Jikei University School of Medicine—approval: 34-142(11293). Adult participant consent was not required because the requirement for written informed consent was waived due to the retrospective nature of the study.
: Adult participant consent was not required because the requirement for written informed consent was waived due to the retrospective nature of the study.
